Tetra Bio-Pharma Launches Medical Cannabis Oil Program

Tetra Bio-Pharma (TSXV:TBP; OTCQB:TBPMF) enters the cannabis oil medical market after it announced the launch of a dedicated oil program and a new trial.
As quoted in the press release:

According to Tetra’s Chief Executive Officer (CEO), Bernard Fortier,” Tetra is in a good position to penetrate this market. We have been preparing for months how to differentiate ourselves within this market while maintaining our corporate vision of an evidence-based approach. The cannabis oil market will be no different for Tetra.
Furthermore, Tetra is announcing that it is supporting a post-marketing study (phase 4 clinical trial) of the use of cannabis oil in the treatment of chronic pain. This trial is driven by the medical experts of Santé Cannabis and will provide much needed safety and efficacy data in this patient population.

As quoted in the press release.

Source: www.marketwired.com